Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JJ6T
|
||||
Former ID |
DNC009159
|
||||
Drug Name |
N6-((+/-)-endo-norborn-2-yl)adenosine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530035] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H23N5O4
|
||||
Canonical SMILES |
C1CC2CC1CC2NC3=NC=NC4=C3N=CN4C5C(C(C(O5)CO)O)O
|
||||
InChI |
1S/C17H23N5O4/c23-5-11-13(24)14(25)17(26-11)22-7-20-12-15(18-6-19-16(12)22)21-10-4-8-1-2-9(10)3-8/h6-11,13-14,17,23-25H,1-5H2,(H,18,19,21)/t8?,9?,10?,11-,13-,14-,17-/m1/s1
|
||||
InChIKey |
YKPCEENRZZBDMC-STHLEMNDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530035] | |
Adenosine A1 receptor | Target Info | Inhibitor | [530035] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [530035] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [530035] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.